Global T-Cell Immunotherapy Market 2020 and Forecast 2029
  2021-02-24      Healthcare And Medical      200

About this Report

We, at GMA, have always studied the market in-depth and have been doing the pressure testing since our inception. Given the current pandemic situation, we all are of consensus that it is a constant now. Owing to which, the report addresses COVID-19 effects on this market too.

Key Companies

Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics

Segmentation Covered

By Type

CAR-T
TCR
TIL Therapies

By Application

Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others

By Region :

Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania
Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland
North America : United States, Canada, Mexico
Middle East & Africa : GCC, North Africa, South Africa
South America : Brazil, Argentina, Columbia, Chile, Peru

In this study, the years considered to estimate the market size of report are as follows:
History Year: 2013-2018
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2029
For the data information by region, company, type and application, 2019 is considered as the base year.

Table Of Content

Chapter 1 Global T-Cell Immunotherapy Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for T-Cell Immunotherapy Market
1.4 Restraints for T-Cell Immunotherapy Market
1.5 Opportunities for T-Cell Immunotherapy Market
1.6 Trends for T-Cell Immunotherapy Market
1.7 COVID-19 Impact Assessment on T-Cell Immunotherapy Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global T-Cell Immunotherapy Market Overview
2.1 Global T-Cell Immunotherapy Market by Product Type
2.1.1 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global T-Cell Immunotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global T-Cell Immunotherapy Market by End User
2.2.1 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global T-Cell Immunotherapy Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global T-Cell Immunotherapy Market by Region
2.3.1 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global T-Cell Immunotherapy Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global T-Cell Immunotherapy Market Outlook (2013-2029)
2.4.1 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global T-Cell Immunotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global T-Cell Immunotherapy Market Y-o-Y Growth Rate by Region
2.8.2 Global T-Cell Immunotherapy Market Y-o-Y Growth Rate by Product Type
2.8.3 Global T-Cell Immunotherapy Market Y-o-Y Growth Rate by End User
2.9 Global T-Cell Immunotherapy Market Share Comparison (2013-2029)
2.9.1 Global T-Cell Immunotherapy Market Share by Region
2.9.2 Global T-Cell Immunotherapy Market Share by Product Type
2.9.3 Global T-Cell Immunotherapy Market Share by End User

Chapter 3 North America T-Cell Immunotherapy Market Overview
3.1 North America T-Cell Immunotherapy Market by Product Type
3.1.1 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America T-Cell Immunotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America T-Cell Immunotherapy Market by End User
3.2.1 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America T-Cell Immunotherapy Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America T-Cell Immunotherapy Market by Region
3.3.1 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America T-Cell Immunotherapy Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America T-Cell Immunotherapy Market Outlook (2013-2029)
3.4.1 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America T-Cell Immunotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America T-Cell Immunotherapy Market Y-o-Y Growth Rate by Region
3.8.2 North America T-Cell Immunotherapy Market Y-o-Y Growth Rate by Product Type
3.8.3 North America T-Cell Immunotherapy Market Y-o-Y Growth Rate by End User
3.9 North America T-Cell Immunotherapy Market Share Comparison (2013-2029)
3.9.1 North America T-Cell Immunotherapy Market Share by Region
3.9.2 North America T-Cell Immunotherapy Market Share by Product Type
3.9.3 North America T-Cell Immunotherapy Market Share by End User

Chapter 4 Europe T-Cell Immunotherapy Market Overview
4.1 Europe T-Cell Immunotherapy Market by Product Type
4.1.1 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe T-Cell Immunotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe T-Cell Immunotherapy Market by End User
4.2.1 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe T-Cell Immunotherapy Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe T-Cell Immunotherapy Market by Region
4.3.1 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe T-Cell Immunotherapy Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe T-Cell Immunotherapy Market Outlook (2013-2029)
4.4.1 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe T-Cell Immunotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe T-Cell Immunotherapy Market Y-o-Y Growth Rate by Region
4.8.2 Europe T-Cell Immunotherapy Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe T-Cell Immunotherapy Market Y-o-Y Growth Rate by End User
4.9 Europe T-Cell Immunotherapy Market Share Comparison (2013-2029)
4.9.1 Europe T-Cell Immunotherapy Market Share by Region
4.9.2 Europe T-Cell Immunotherapy Market Share by Product Type
4.9.3 Europe T-Cell Immunotherapy Market Share by End User

Chapter 5 Asia Pacific T-Cell Immunotherapy Market Overview
5.1 Asia Pacific T-Cell Immunotherapy Market by Product Type
5.1.1 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific T-Cell Immunotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific T-Cell Immunotherapy Market by End User
5.2.1 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific T-Cell Immunotherapy Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific T-Cell Immunotherapy Market by Region
5.3.1 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific T-Cell Immunotherapy Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific T-Cell Immunotherapy Market Outlook (2013-2029)
5.4.1 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific T-Cell Immunotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific T-Cell Immunotherapy Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific T-Cell Immunotherapy Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific T-Cell Immunotherapy Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific T-Cell Immunotherapy Market Share Comparison (2013-2029)
5.9.1 Asia Pacific T-Cell Immunotherapy Market Share by Region
5.9.2 Asia Pacific T-Cell Immunotherapy Market Share by Product Type
5.9.3 Asia Pacific T-Cell Immunotherapy Market Share by End User

Chapter 6 South America T-Cell Immunotherapy Market Overview
6.1 South America T-Cell Immunotherapy Market by Product Type
6.1.1 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America T-Cell Immunotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America T-Cell Immunotherapy Market by End User
6.2.1 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America T-Cell Immunotherapy Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America T-Cell Immunotherapy Market by Region
6.3.1 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America T-Cell Immunotherapy Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America T-Cell Immunotherapy Market Outlook (2013-2029)
6.4.1 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America T-Cell Immunotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America T-Cell Immunotherapy Market Y-o-Y Growth Rate by Region
6.8.2 South America T-Cell Immunotherapy Market Y-o-Y Growth Rate by Product Type
6.8.3 South America T-Cell Immunotherapy Market Y-o-Y Growth Rate by End User
6.9 South America T-Cell Immunotherapy Market Share Comparison 2013-2029
6.9.1 South America T-Cell Immunotherapy Market Share by Region
6.9.2 South America T-Cell Immunotherapy Market Share by Product Type
6.9.3 South America T-Cell Immunotherapy Market Share by End User

Chapter 7 MEA T-Cell Immunotherapy Market Overview
7.1 MEA T-Cell Immunotherapy Market by Product Type
7.1.1 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA T-Cell Immunotherapy Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA T-Cell Immunotherapy Market by End User
7.2.1 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA T-Cell Immunotherapy Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA T-Cell Immunotherapy Market by Region
7.3.1 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA T-Cell Immunotherapy Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA T-Cell Immunotherapy Market Outlook (2013-2029)
7.4.1 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA T-Cell Immunotherapy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA T-Cell Immunotherapy Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA T-Cell Immunotherapy Market Y-o-Y Growth Rate by Region
7.8.2 MEA T-Cell Immunotherapy Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA T-Cell Immunotherapy Market Y-o-Y Growth Rate by End User
7.9 MEA T-Cell Immunotherapy Market Share Comparison (2013-2029)
7.9.1 MEA T-Cell Immunotherapy Market Share by Region
7.9.2 MEA T-Cell Immunotherapy Market Share by Product Type
7.9.3 MEA T-Cell Immunotherapy Market Share by End User

Chapter 8 Global T-Cell Immunotherapy Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included :
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics

Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Enquiry Before Buying

Select User Format

OUR CLIENT